Responsible for the management of novel academic projects from process development, through scale-up to GMP manufacture.Working in Technology Readiness Levels TRL 4-7 (late preclinical to phase II clinical trials in man) supporting 'Bench to Bedside' or 'Bench to Bush' Translational Research mainly in the malaria,TB,HIV, flu or cancer vaccines field. The CBF provides the link between academic research and clinical drug development, allowing our collaborators to progress into clinical trials.The Clinical BioManufacturing Facility has 18 years’ experience producing biological Investigational Medicinal Products (IMPs) according to the principles of GMP for early phase clinical trials. The CBF holds a Manufacturer’s Authorisation for Investigational Medicinal Products (MA (IMPs)) from the Medicines and Healthcare products Regulatory Agency (MHRA) for a wide range of Advanced Therapy Investigational Medicinal Products (ATMPs /IMPS) including labelling activities for clinical trials.